Navigation Links
Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models

afety profiles in larger animals at dose levels which are in excess of an efficacious dose determined in the xenograft models.

"Antibody-drug conjugates exploit the specificity of antibodies and the potency of cytotoxic agents to destroy cancer cells," said Nils Lonberg, PhD, Senior Vice President and Science Director at Medarex. "We believe that the anti-tumor activity from these preclinical antibody-drug conjugate studies is quite compelling, and we look forward to fully exploring the safety and therapeutic activity and application of these programs in future clinical trials."

About Medarex

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb(R) technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners. More than 30 of these therapeutic product candidates derived from Medarex technology are in human clinical testing or have had INDs submitted for such trials, with six of the most advanced product candidates currently in Phase III clinical trials. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs. For more information about Medarex, visit its website at www.medarex.com.

Medarex Statement on Cautionary Factors

Except for the historical information presented herein, matters discussed herein may constitute forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements exp
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
7. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
8. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
11. BioCryst Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference
Post Your Comments:
(Date:4/21/2015)... , April 21, 2015  Inmark,s acquisition ... leader in Dangerous Goods Training, specifically Division 6.2.  ... 6.2 Dangerous Goods training programs focusing on IATA, ... Postal Union regulations. "We were particularly ... well as their multilingual internet training programs," said ...
(Date:4/21/2015)... , April 21, 2015 The global ... a CAGR of 8.2% from 2014 to 2019. ... hold larger shares in the global dermatology ... diagnostic devices market is mainly attributed to a wide ... disorders, growing demand of dermatologists, and technological advancements made ...
(Date:4/21/2015)... April 21, 2015 The non-invasive & minimally invasive cardiac output monitoring devices ... Geographically, Europe is segmented as Germany , ... and Rest of Europe (RoE). Germany ... & minimally invasive cardiac output monitoring devices market around 35.2% in 2014 followed by ... Netherlands , Sweden , Poland , ...
Breaking Medicine Technology:Inmark's Acquisition Of Saf-T-Pak Results In Expansion Of Its Dangerous Goods Training Portfolio 2Dermatology Diagnostic Devices Market by Product, by End-User - Global Forecast to 2019 2Dermatology Diagnostic Devices Market by Product, by End-User - Global Forecast to 2019 3European Non-invasive and Minimally Invasive Cardiac Output Monitoring Devices Market by Type, by End-User - Forecast to 2019 2European Non-invasive and Minimally Invasive Cardiac Output Monitoring Devices Market by Type, by End-User - Forecast to 2019 3
... ... Lake City, SALT LAKE CITY, ... identified specific genetic markers,for scoliosis. The data from this research made it ... in,patients with Adolescent Idiopathic Scoliosis., This groundbreaking research was presented to ...
... Potential therapy for inherited conditions, ROCHESTER, Minn., ... stem cells can be used to regenerate,heart tissue ... the discovery was expedited by the editors of ... of the journal,s Web site at, http://stemcells.alphamedpress.org/ ., ...
Cached Medicine Technology:Researchers at Axial Biotech Develop a DNA Test for Scoliosis 2Stem Cell Regeneration Repairs Congenital Heart Defect 2
(Date:4/21/2015)... (PRWEB) April 21, 2015 Patients seeking ... have a high-quality choice for receiving treatment at a ... patient safety and quality of care in the greater ... its bariatric surgical center has been accredited as a ... and Quality Improvement Program (MBSAQIP), a joint program of ...
(Date:4/21/2015)... April 21, 2015 The National ... Dina Tyler, Felton Institute’s Coordinator of Peer and ... in Early Psychosis) Program in Alameda County, California, ... Specialist of the Year Award at the National ... of behavioral health. , The Inspiring Hope Awards, ...
(Date:4/21/2015)... 21, 2015 On April 2, 2015, ... to Achieve Kylie Jenner Lips With Disastrous ... injured themselves while attempting an at-home lip augmentation ... is that creating an airlock around one’s mouth for ... plump and achieve Kylie Jenner’s now famous pout. (see: ...
(Date:4/21/2015)... Dallas, Texas (PRWEB) April 22, 2015 ... Pipeline Review, H1 2015” provides comparative analysis ... The report strengthens R&D pipelines by identifying ... and best-in-class products. Complete report with TOC ... , The report also reviews key players ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 The ... than 275 leading life sciences organizations, released the ... Radcliffe regarding California State Assembly Bill (AB) 463: ... dedicated to the development of treatments and cures ... have deep concerns regarding AB 463, the so-called ...
Breaking Medicine News(10 mins):Health News:Florida Hospital Tampa Achieves National Accreditation from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program 2Health News:Florida Hospital Tampa Achieves National Accreditation from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program 3Health News:Florida Hospital Tampa Achieves National Accreditation from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program 4Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 2Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 3Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 4Health News:Celebrity Cosmetic Surgeon Comments on Report of Teen Girls Injuring Themselves Attempting Kylie Jenner-Inspired Twitter Challenge 2Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4Health News:California Healthcare Institute Statement on AB 463 2Health News:California Healthcare Institute Statement on AB 463 3
... failure, slowed cell growth, study says , , WEDNESDAY, Jan. ... many years to treat irregular heart rhythms and heart ... , Cancer cells need to create new blood vessels ... and need to switch on genes that produce a ...
... Seabrook House, an internationally recognized inpatient treatment center, is pleased ... in 2009. The following is just a few ... recovery from addiction is possible and that treatment works. Seabrook ... who needs it and to educate the public at large ...
... 7 Synthetech, Inc.,(OTC Bulletin Board: NZYM) ... for their outstanding accomplishments in the areas ... and Operations, and Stakeholder,Communications. The Silver ... Manufacturers Association (SOCMA) and sponsored by ChemStewards,SOCMA,s ...
... INDIANAPOLIS, Jan. 7 Eli Lilly and Company,(NYSE: ... quarter and,full year of 2008 on Thursday, January 29, 2009. ... with the investment community and media to further,detail the company,s ... will be held from 9:00 a.m. to 10:00 a.m. EST.,Investors, ...
... , To Manage Family,s Dental Care and Oral HealthAcademy ... Everyone knows that Moms are the ones ... it,s no wonder that, when it comes to a family,s ... But until now, busy Moms were not sure where to ...
... be as susceptible, study suggests , , WEDNESDAY, Jan. 7 (HealthDay ... of "screen time" a day watching TV, surfing the Web ... new Australian study finds. , Interestingly, boys who were part ... to "sit and be fit," said lead author Louise Hardy, ...
Cached Medicine News:Health News:Heart Drug May Be a Cancer Fighter 2Health News:Seabrook House Embraces the New Year with New Programs 2Health News:Seabrook House Embraces the New Year with New Programs 3Health News:Synthetech Earns National Recognition for Performance Improvement Program 2Health News:Synthetech Earns National Recognition for Performance Improvement Program 3Health News:KnowYourTeeth.com Launches as the Internet's New Go-To Resource for 'All Things Dental' 2Health News:KnowYourTeeth.com Launches as the Internet's New Go-To Resource for 'All Things Dental' 3Health News:KnowYourTeeth.com Launches as the Internet's New Go-To Resource for 'All Things Dental' 4Health News:KnowYourTeeth.com Launches as the Internet's New Go-To Resource for 'All Things Dental' 5Health News:More 'Screen Time' Linked to Poor Fitness in Girls 2
... based on the competition principle and the ... present in the sample and a fixed ... compete for the binding sites of a ... After one hour incubation the microtiterplate is ...
EL-RF-IgM is high sensitivity quantitative rheumatoid factor IgM....
Latex agglutination test for the qualitative and semiquantitative determination of rheumatoid factor in serum....
... with the SYNCHRON CX4 PRO, which ... and automated technologies, your laboratory can ... The SYNCHRON CX4 PRO consolidates DATs, ... tests, such as thyroid, HbA1c and ...
Medicine Products: